Go Pro
NASDAQ:UTMD

Utah Medical Products (UTMD) Stock Price, News & Analysis

Utah Medical Products logo
$70.52 +0.95 (+1.37%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$70.46 -0.06 (-0.09%)
As of 07/31/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Utah Medical Products Stock (NASDAQ:UTMD)

Advanced

Key Stats

Today's Range
$69.41
$70.76
50-Day Range
$64.18
$73.97
52-Week Range
$53.66
$75.75
Volume
22,532 shs
Average Volume
30,877 shs
Market Capitalization
$224.25 million
P/E Ratio
21.50
Dividend Yield
1.76%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Utah Medical Products, Inc. (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂). Utah Medical Products also offers solutions for interventional pulmonology and endoscopy, providing healthcare professionals with a broad range of devices designed, tested and manufactured under clean‐room conditions to meet stringent regulatory standards.

Utah Medical Products serves hospitals, surgical centers and long‐term care facilities through a combination of direct sales and an international network of distributors. Its customer base spans North America, Europe, Asia and Latin America, reflecting ongoing efforts to expand its geographic footprint and respond to global demand for reliable airway management and monitoring technologies.

The company is managed by an experienced leadership team with backgrounds in medical device engineering, regulatory affairs and quality assurance. This team guides Utah Medical Products in advancing its product pipeline, maintaining compliance with international standards and ensuring timely delivery of sterile, single‐use devices to healthcare providers worldwide.

AI Generated. May Contain Errors.

Utah Medical Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

UTMD MarketRank™: 

Utah Medical Products scored higher than 24% of companies evaluated by MarketBeat, and ranked 805th out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Utah Medical Products has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Utah Medical Products has only been the subject of 1 research reports in the past 90 days.

  • Read more about Utah Medical Products' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Utah Medical Products is 21.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.25.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Utah Medical Products is 21.50, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 281.76.

  • Price to Book Value per Share Ratio

    Utah Medical Products has a P/B Ratio of 1.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.78% of the float of Utah Medical Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Utah Medical Products has a short interest ratio ("days to cover") of 7.72.
  • Change versus previous month

    Short interest in Utah Medical Products has recently increased by 1.00%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Utah Medical Products pays a meaningful dividend of 1.78%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Utah Medical Products has only been increasing its dividend for 3 years.

  • Dividend Coverage

    The dividend payout ratio of Utah Medical Products is 37.80%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Utah Medical Products' dividend.
  • News Sentiment

    Utah Medical Products has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.91 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Utah Medical Products this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Utah Medical Products insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    8.00% of the stock of Utah Medical Products is held by insiders.

  • Percentage Held by Institutions

    69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Utah Medical Products' insider trading history.
Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UTMD Stock News Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.31
See More Headlines

UTMD Stock Analysis - Frequently Asked Questions

Utah Medical Products' stock was trading at $55.96 at the beginning of the year. Since then, UTMD shares have increased by 26.0% and is now trading at $70.52.

Utah Medical Products, Inc. (NASDAQ:UTMD) released its quarterly earnings data on Thursday, July, 23rd. The medical instruments supplier reported $0.84 EPS for the quarter. The medical instruments supplier had revenue of $8.53 million for the quarter. Utah Medical Products had a trailing twelve-month return on equity of 8.79% and a net margin of 29.04%.

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Utah Medical Products investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and AUO (AUOTY).

Company Calendar

Record date for 7/3 Dividend
6/17/2026
Ex-Dividend for 7/3 Dividend
6/17/2026
Dividend Payable
7/03/2026
Last Earnings
7/23/2026
Today
8/01/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:UTMD
CIK
706698
Employees
180
Year Founded
1978

Profitability

EPS (Trailing Twelve Months)
$3.28
Trailing P/E Ratio
21.50
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$11.29 million
Net Margins
29.04%
Pretax Margin
35.79%
Return on Equity
8.79%
Return on Assets
8.53%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
28.64
Quick Ratio
26.15

Sales & Book Value

Annual Sales
$38.52 million
Price / Sales
5.82
Cash Flow
$4.52 per share
Price / Cash Flow
15.59
Book Value
$37.23 per share
Price / Book
1.89

Miscellaneous

Outstanding Shares
3,180,000
Free Float
2,929,000
Market Cap
$224.25 million
Optionable
Not Optionable
Beta
0.36

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:UTMD) was last updated on 8/1/2026 by MarketBeat.com Staff.
From Our Partners